AMRX vs POOL · P/E 44, rev $2.79B vs P/E 18, rev $5.31B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the AMRX and POOL stock pages for the full models.
Not investment advice.